Legislative record

S 36STATE · New YorkIntroduced

Relates to the labeling of mifepristone, misoprostol, and their generic alternatives

Permits prescription labels for mifepristone, misoprostol, and their generic alternatives to include the name of the prescribing health care practice instead of the name of the prescriber at the prescriber's request.

Voted 2/3/2025

Roll-call record

How representatives voted

146 yea·68 nay·19 other

Docket history

Action history

  1. 2/3/2025DELIVERED TO GOVERNOR
  2. 2/3/2025SIGNED CHAP.7
  3. 2/3/2025APPROVAL MEMO.1
  4. 1/22/2025SUBSTITUTED FOR A2145A
  5. 1/22/2025ORDERED TO THIRD READING RULES CAL.61
  6. 1/22/2025PASSED ASSEMBLY
  7. 1/22/2025RETURNED TO SENATE
  8. 1/21/2025COMMITTEE DISCHARGED AND COMMITTED TO RULES
  9. 1/21/2025ORDERED TO THIRD READING CAL.99
  10. 1/21/2025PASSED SENATE